Susquehanna International Group, LLP Dare Bioscience, Inc. Transaction History
Susquehanna International Group, LLP
- $527 Billion
- Q2 2024
A detailed history of Susquehanna International Group, LLP transactions in Dare Bioscience, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 34,958 shares of DARE stock, worth $157,311. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,958
Previous 26,327
32.78%
Holding current value
$157,311
Previous $12,000
8.33%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding DARE
# of Institutions
10Shares Held
813KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY204KShares$916,3440.0% of portfolio
-
Interwest Venture Management CO62.1KShares$279,2920.14% of portfolio
-
Jane Street Group, LLC New York, NY11.1KShares$50,1520.0% of portfolio
-
American Portfolios Advisors Holbrook, NY1KShares$4,5000.0% of portfolio
-
Bank Of America Corp Charlotte, NC981Shares$4,4140.0% of portfolio
About Dare Bioscience, Inc.
- Ticker DARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,820,896
- Market Cap $382M
- Description
- Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...